Buphthalmos - Symptoms, Causes, Treatment & Prevention

Overview

Buphthalmos (pronounced ) is a medical term that describes an abnormal enlargement of the eyeball, most often due to markedly increased intra‑ocular pressure (IOP) in infancy or early childhood. The word originates from the Greek “βούφας” (bóphos, meaning “ox”) and “ophthalmos” (eye), reflecting the “ox‑eye” appearance of a markedly swollen globe.

While other conditions can cause globe enlargement, buphthalmos is most commonly associated with congenital or early‑onset glaucoma. It is a rare disease; worldwide incidence of primary congenital glaucoma (the leading cause of buphthalmos) is estimated at 1 in 10,000–20,000 live births, with higher rates in populations with consanguineous marriage (up to 1 in 1,250 in some Middle‑Eastern communities) [CDC][Mayo Clinic].

Because the condition develops in the first months of life, early detection is crucial to prevent irreversible visual loss.

Symptoms

Symptoms may be subtle at first, especially in newborns who cannot verbalize discomfort. A careful eye examination is often needed. The most common findings include:

• Enlarged corneal diameter (≥12 mm in newborns, >13 mm in infants). The cornea may appear cloudy or hazy.
• Increased intra‑ocular pressure (IOP) – not directly observable, but inferred from other signs.
• Photophobia – sensitivity to bright light, often causing the infant to turn the head away.
• Excessive tearing (epiphora) – watery eyes without infection.
• Blurry or diminished vision – may present as poor fixation, delayed visual milestones, or inability to track objects.
• Haab’s striae – horizontal breaks in Descemet’s membrane visible as fine lines on the cornea.
• Steep corneal curvature – leading to astigmatism or irregular refractive error.
• White reflex (leukocoria) – occasionally seen if the cornea becomes opaque.

In severe cases, the globe can become so enlarged that the eyelids are stretched, giving a “bulging” appearance.

Causes and Risk Factors

Primary causes

• Primary congenital glaucoma (PCG) – a developmental defect of the trabecular meshwork and Schlemm’s canal that impedes aqueous outflow.
• Secondary glaucoma – caused by other ocular anomalies (e.g., anterior segment dysgenesis, Sturge‑Weber syndrome, aniridia).

Genetic factors

Over 30 % of PCG cases have an identifiable genetic component. The most common genes are:

• CYLD (CYP1B1) – mutations account for 10‑30 % of PCG worldwide.
• FOXC1 and LTBP2 – less frequent but documented in specific ethnic groups.

Risk factors

• Positive family history of congenital glaucoma.
• Consanguineous marriage (higher prevalence in certain Middle Eastern and South Asian populations).
• Associated systemic conditions (e.g., neurofibromatosis type 1, Axenfeld‑Rieger syndrome).
• Prematurity or low birth weight – some studies suggest a modest increase in risk.

Diagnosis

Diagnosing buphthalmos involves a combination of clinical eye examination, imaging, and measurement of intra‑ocular pressure. Early referral to a pediatric ophthalmologist is essential.

Key diagnostic steps

1. Visual inspection – measurement of corneal diameter with a caliper; a value >12 mm in a newborn is abnormal.
2. Tonometry – handheld devices (e.g., Perkins, iCare) to estimate IOP. Normal pediatric IOP is 10‑21 mm Hg; values >21 mm Hg raise suspicion.
3. Gonioscopy – evaluation of the anterior chamber angle; in PCG the angle is typically malformed.
4. Ultrasound biomicroscopy (UBM) or Anterior Segment OCT – provides detailed images of angle structures and corneal thickness.
5. Fundus examination – looking for optic nerve cupping, retinal changes, or associated anomalies.
6. Genetic testing – indicated when a hereditary form is suspected, especially in families with known mutations.

Differential diagnosis

Conditions that can mimic buphthalmos include:

• Corneal dystrophies (e.g., congenital stromal dystrophy)
• Microphthalmia with cyst (opposite end of size spectrum)
• Orbital tumors causing globe protrusion (rare in infancy)

Treatment Options

Because the underlying problem is elevated IOP, treatment aims to lower pressure, preserve visual function, and remodel the anterior segment when possible.

Medical therapy (initial)

• Topical β‑blockers (timolol 0.25 % or 0.5 %) – reduce aqueous production.
• Prostaglandin analogs (latanoprost, bimatoprost) – increase uveoscleral outflow; used cautiously in infants.
• Carbonic anhydrase inhibitors (dorzolamide, brinzolamide) – lower IOP by decreasing aqueous formation.
• Alpha‑agonists (brimonidine) – adjunctive, not first‑line in very young children due to systemic side effects.
• Systemic oral carbonic anhydrase inhibitors (acetazolamide) may be prescribed short‑term for acute IOP elevation.

Medical therapy alone rarely provides long‑term control in PCG; it is generally a bridge to surgery.

Surgical interventions (definitive)

1. Goniotomy – incision of the trabecular meshwork under direct visualization; first‑line for infants when corneal clarity allows.
2. Trabeculotomy – external approach opening the Schlemm’s canal; useful when cornea is cloudy.
3. Combined trabeculotomy‑goniotomy – offers higher success rates in some series.
4. Glaucoma drainage devices (Ahmed, Baerveldt implants) – placed when angle surgery fails or in complex eyes.
5. Cyclophotocoagulation – laser ablation of ciliary body to reduce aqueous production; reserved for refractory cases.
6. Clear‑corneal or penetrating keratoplasty – indicated when corneal opacity severely impairs vision after IOP control.

Lifestyle & supportive measures

• Regular follow‑up visits (every 3–6 months initially).
• Protective eyewear to guard against trauma.
• Adherence to prescribed drops—set reminders or use a medication chart.
• Early visual rehabilitation (spectacles, patching) to prevent amblyopia.

Living with Buphthalmos

Managing buphthalmos is a team effort involving ophthalmologists, pediatricians, genetic counselors, and often low‑vision specialists.

Practical daily tips

• Medication routine – keep bottles in a cool, dry place; avoid contamination.
• Check IOP at home? – Not practical; rely on scheduled clinic measurements.
• Eye protection – use soft goggles during play to prevent accidental rubbing or impact.
• Screen time – limit prolonged close‑up activities; encourage frequent breaks to reduce eye strain.
• Developmental monitoring – track milestones (visual tracking, hand‑eye coordination); inform the physician of any delays.
• Family education – ensure caregivers know how to instill drops correctly (pull lower lid, squeeze, avoid touching tip to eye).

Psychosocial aspects

Children with visible eye enlargement may experience self‑esteem issues as they grow. Early counseling, support groups, and open communication with teachers can foster a positive environment.

Prevention

Because many cases are genetic, primary prevention is limited. However, certain actions can reduce risk or facilitate earlier detection:

• Pre‑conception genetic counseling for families with known PCG mutations.
• Avoiding consanguineous marriages where cultural practices allow alternatives.
• Routine newborn eye screening (red reflex test) – detects corneal opacity or abnormal size.
• Prompt evaluation of any eyelid swelling, tearing, or photophobia in infants.

Complications

If left untreated or inadequately controlled, buphthalmos can lead to serious, often irreversible outcomes:

• Progressive visual loss – due to optic nerve damage from sustained high IOP.
• Amblyopia – “lazy eye” resulting from deprivation or refractive error.
• Corneal decompensation – scarring or endothelial cell loss leading to permanent opacity.
• Anterior segment dysgenesis – further structural instability, making future surgeries more difficult.
• Secondary glaucoma in adulthood – patients remain at risk throughout life.
• Psychological impact – reduced quality of life, especially if visual function declines.

When to Seek Emergency Care

References

• American Academy of Ophthalmology. Primary Congenital Glaucoma. 2023. https://www.aao.org/eye-health/diseases/primary-congenital-glaucoma
• Cleveland Clinic. Congenital Glaucoma. 2022. https://my.clevelandclinic.org/health/diseases/16439-congenital-glaucoma
• Centers for Disease Control and Prevention. Vision Health Initiative: Congenital Glaucoma. 2021. https://www.cdc.gov/visionhealth/congenitalglaucoma.html
• Mayo Clinic. Congenital Glaucoma. 2023. https://www.mayoclinic.org/diseases-conditions/congenital-glaucoma/symptoms-causes/syc-20372421
• World Health Organization. Childhood Blindness and Visual Impairment. 2020. https://www.who.int/vision/en/
• Quigley HA, Broman AT. “The number of people with glaucoma worldwide in 2010 and 2020.” *Br J Ophthalmol*. 2006;90:262‑266.
• Al‑Bazi HR et al. “Genetics of Primary Congenital Glaucoma.” *Ophthalmic Genet.* 2021;42:123‑132.